InsidersTradesSigma
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the full record of transactions filed by FINKELSTEIN J J, Chief Executive Officer. Officer active across 1 company, notably Regenerx Biopharmaceuticals INC. Cumulatively, 2 reports have been logged. Split: 2 buys · 0 sell. Total volume traded: €25k. History available since 30 June 2021. The latest transaction was filed on 30 June 2021 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
2 of 2 declarations
FINKELSTEIN J J serves as President and CEO at Regenerx Biopharmaceuticals Inc. He is responsible for the strategic and operational direction of the company. J J plays a key role in business development and technological innovation, contributing to the growth of Regenerx. His expertise in the biopharmaceutical sector is essential for navigating a competitive environment.